Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine.
about
Effect of vaccine administration modality on immunogenicity and efficacy.Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizingTherapeutic antibodies directed at G protein-coupled receptorsAerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses.A Linear Epitope in the N-Terminal Domain of CCR5 and Its Interaction with Antibody.Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human PapillomavirusA vaccine against CCR5 protects a subset of macaques upon intravaginal challenge with simian immunodeficiency virus SIVmac251.Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective.Antigen delivery by virus-like particles for immunotherapeutic vaccination.The application of virus-like particles as vaccines and biological vehicles.Monoclonal antibodies: technologies for early discovery and engineering.
P2860
Q27692376-0B0CD304-D6C3-4CB1-8AAA-56A338B8F8E4Q33569555-6088B3B3-43EB-4B1A-AD98-97EA70199754Q33967341-E7B7E27D-CAE7-4895-8151-64E097D0EBBBQ34445135-E12DBBD1-0256-455B-9AF5-450BECEE54B2Q35042602-201E78E3-7D9A-46B6-9760-D4BAD7FC59E5Q35648543-DEBA4CFC-74FF-4BC3-8A6B-8295E6D55B46Q36858686-996E7C31-6A75-4B57-AC19-9100CED5E2ACQ37547093-F207AA5A-D7A7-4017-92C8-860C7372501DQ37792984-C7E121F4-4B41-4DB4-BFAD-95CF62D65E4DQ38066148-06F3CAD6-36BB-4D06-B8BA-E327E105A719Q38285854-2EC269C6-74CC-426C-9837-D2EE0E92E1B3Q38603912-5C25D25B-7682-477D-B944-B235F39AAF79Q38633596-0C477882-A5AD-4881-B94D-895D360C167F
P2860
Induction of mucosal and systemic antibody responses against the HIV coreceptor CCR5 upon intramuscular immunization and aerosol delivery of a virus-like particle based vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Induction of mucosal and syste ...... s-like particle based vaccine.
@en
Induction of mucosal and syste ...... s-like particle based vaccine.
@nl
type
label
Induction of mucosal and syste ...... s-like particle based vaccine.
@en
Induction of mucosal and syste ...... s-like particle based vaccine.
@nl
prefLabel
Induction of mucosal and syste ...... s-like particle based vaccine.
@en
Induction of mucosal and syste ...... s-like particle based vaccine.
@nl
P2093
P2860
P921
P1433
P1476
Induction of mucosal and syste ...... s-like particle based vaccine.
@en
P2093
Bryce Chackerian
Hugh D Smyth
Paul Durfee
Zoe Hunter
P2860
P304
P356
10.1016/J.VACCINE.2009.10.035
P407
P577
2009-10-20T00:00:00Z